Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. - Wikidata - awgldk - TriplyDB

Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.

Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.

http://www.wikidata.org/entity/Q34518820

about

Dosage adjustment in renal insufficiency Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO β-Blocker dialyzability and mortality in older patients receiving hemodialysis.Cardiovascular agents.Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.The intuitive case for β-blockers in patients with ESRD.Predicative calculation of the efficiency of hemodialysis or hemoperfusion for the removal of drugs from the body.β-Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial.

P2860

Q34449866-94DA0AEE-BDA9-41DE-AA10-3D0A59E6BDB2 Q34512809-EC73A9D7-0984-4DC1-9F47-FF2FC46441D2 Q35210117-F9A2DEC4-8C76-43A2-8946-D7418C9A5CE5 Q35228567-EC96CB14-9088-44B5-AA70-862D83E0E9D2 Q37808686-0C34BBA9-FFE0-4DBC-8A59-A4D13683302E Q41893918-B7AABCE8-51B3-42E0-A167-C3AF1CF74F31 Q51636115-2BF1ECE3-B62A-4A17-8AB6-3382B6C614B7 Q52681079-3591263B-422E-479C-902C-653F7C63FF1E Q53838798-BBD17E62-2A53-4EB8-8BE8-DABADB3A5900

P2860

Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.

http://www.wikidata.org/entity/Q34518820

description

1980 nî lūn-bûn

@nan

1980 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1980 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1980年の論文

@ja

1980年論文

@yue

1980年論文

@zh-hant

1980年論文

@zh-hk

1980年論文

@zh-mo

1980年論文

@zh-tw

1980年论文

@wuu

name

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@ast

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@en

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@nl

type

label

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@ast

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@en

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@nl

prefLabel

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@ast

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@en

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@nl

P1433

Q34518820-A5B8D829-3C88-4ED3-9CFE-2566756AA91E

P1476

Q34518820-0701917D-51B1-459E-9DD5-7F2E9D399F37

P2093

Q34518820-029F00DE-B47D-40EB-9BF9-36C86940A56F

Q34518820-18B6BAF3-E1C3-401B-938C-9E3600300EEF

Q34518820-671B9E87-2AFF-4BEB-B67F-4FC9839F9EFB

Q34518820-88639757-90E5-48C3-B54B-BB83B57BFDD6

Q34518820-BEDF3824-3715-4890-9E9B-15EA5A203AE3

Q34518820-C5FF8EF7-6D94-426E-980B-BB7B045F8361

Q34518820-D56BE18B-4D75-427B-9460-B84CEBC5FC3A

P2860

Q34518820-230DB0AD-520B-4457-B164-28313BB9D56E

Q34518820-26DB2B4F-54B8-4FA6-9BD7-23BCD96925B3

Q34518820-2D8A15F5-631F-4BA3-8E09-EB503A1A89A2

Q34518820-45E9A792-3F68-416C-B885-245A8CCB9A52

Q34518820-7C672C7C-3B5E-45BE-845D-49755401F0AE

Q34518820-AED3998B-5D7F-4A70-BF32-9DD81E9E5FAC

Q34518820-B26A9F75-4CA6-401F-B745-273E288D7E50

Q34518820-B6D220C6-3DC1-4150-BFB1-897DEEE52C4B

Q34518820-C77F54A4-DBD7-4715-A7BD-0D1819463E36

Q34518820-CDB93F01-412E-4B47-9BC0-3C43029C8155

P304

Q34518820-A0EFD31B-4A79-4C7A-96FA-AD3C85769F63

P31

Q34518820-68D01366-4957-4678-9496-E63B3A302588

P356

Q34518820-AD41C054-1B1A-4414-BBFB-A9152CF5FC8B

P407

Q34518820-7A200ED6-D808-473C-AC59-3030F9AAE1A5

P433

Q34518820-F9E8FA78-919E-48AF-B685-6883787AB864

P478

Q34518820-86687DE5-7AE7-40C3-8837-8EBF47990D18

P577

Q34518820-F49F0175-357C-4583-99C8-21DBE0516642

P5875

Q34518820-CF1B4C88-C50C-484A-87C4-DD9AF9629CBC

P698

Q34518820-CD905939-8102-4826-9C81-4BCEE889070D

P932

Q34518820-31929D13-30D5-466B-9052-7B12B19BDC1F

P356

J.1365-2125.1980.TB01065.X

P1433

British Journal of Clinical Pharmacology

P1476

Pharmacokinetics of atenolol i ...... nd influence of haemodialysis.

@en

P2093

Aubert P

http://www.w3.org/2001/XMLSchema#string

Baglin A

http://www.w3.org/2001/XMLSchema#string

Decourt S

http://www.w3.org/2001/XMLSchema#string

Domart M

http://www.w3.org/2001/XMLSchema#string

Flouvat B

http://www.w3.org/2001/XMLSchema#string

Goupil A

http://www.w3.org/2001/XMLSchema#string

Potaux L

http://www.w3.org/2001/XMLSchema#string

P2860

A new type of cardioselective adrenoceptive blocking drug

Metabolism of atenolol in man

Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

[Spectrofluorimetric estimation in biological fluids of a new beta-blockader: atenolol. Application to its pharmacokinetic study (author's transl)]

Artificial kidney function; kinetics of hemodialysis.

The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Artificial kidneys and clearance calculations.

Controlled study of atenolol in treatment of hypertension.

Pharmacodynamics of practolol in chronic renal failure.

P304

379-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1980.TB01065.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

1980-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15821355

http://www.w3.org/2001/XMLSchema#string

P698

7378254

http://www.w3.org/2001/XMLSchema#string

P932

1429992

http://www.w3.org/2001/XMLSchema#string